Maintenance phase treatment with divalproex [valproate semisodium] for post traumatic stress disorder

Trial Profile

Maintenance phase treatment with divalproex [valproate semisodium] for post traumatic stress disorder

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 28 Apr 2017

At a glance

  • Drugs Valproate semisodium (Primary) ; Valproic acid
  • Indications Post-traumatic stress disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Apr 2017 Status changed from completed to discontinued as the funding had expired.
    • 04 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top